The emergence of stem cell therapy for patients with congenital heart disease

Circulation Research

Volumn 116, Issue 4, 2015, Pages 566-569

  Wehman, Brody ^a   Kaushal, Sunjay ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY GROWTH; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARDIAC STEM CELL; CAVOPULMONARY CONNECTION; CLINICAL TRIAL (TOPIC); CONGENITAL HEART DISEASE; EDITORIAL; FUNCTIONAL STATUS; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; PALLIATIVE THERAPY; PRIORITY JOURNAL; SCAR FORMATION; STEM CELL TRANSPLANTATION; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HYPOPLASTIC LEFT HEART SYNDROME; MALE; PROCEDURES; TRANSPLANTATION;

FEMALE; HEART FAILURE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; MALE; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STROKE VOLUME; VENTRICULAR FUNCTION, RIGHT;

EID: 84924206504     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.305821     Document Type: Editorial

References (24)

1. Rossano JW, Shaddy RE. Heart failure in children: etiology and treatment. J Pediatr. 2014;165:228-233. doi: 10.1016/j.jpeds.2014.04.055.
2. Ishigami S, Ohtsuki S, Tarui S, et al. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2015;116:653-664. doi: 10.1161/CIRCRESAHA.116.304671.
3. Karantalis V, DiFede DL, Gerstenblith G, et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the prospective randomized study of mesenchymal stem cell therapy in patients undergoing cardiac surgery (prometheus) trial. Circ Res. 2014;114:1302-1310. doi: 10.1161/CIRCRESAHA.114.303180.
4. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The poseidon randomized trial. JAMA. 2012;308:2369-2379.
5. Heldman AW, DiFede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the tac-hft randomized trial. JAMA. 2014;311:62-73. doi: 10.1001/jama.2013.282909.
6. Selem SM, Kaushal S, Hare JM. Stem cell therapy for pediatric dilated cardiomyopathy. Curr Cardiol Rep. 2013;15:369. doi: 10.1007/s11886-013-0369-z.
7. Karantalis V, Schulman IH, Balkan W, Hare JM. Allogeneic cell therapy: a new paradigm in therapeutics. Circ Res. 2015;116:12-15. doi: 10.1161/CIRCRESAHA.114.305495.
8. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277-2286. doi: 10.1016/j.jacc.2009.06.055.
9. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV. Intracoronary car-diosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379:895-904. doi: 10.1016/S0140-6736(12)60195-0.
10. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-1857. doi: 10.1016/S0140-6736(11)61590-0.
11. Makkar R, Schatz R, Traverse J, Hamer A, Beattie K, Smith RR, Kivel F, Marbán L, Marbán E, Henry TD. Abstract 20536: allogeneic heart stem cells to achieve myocardial regeneration (allstar): the one year phase I results. Circulation. 2014;130:A20536.
12. Davies B, Elwood NJ, Li S, Cullinane F, Edwards GA, Newgreen DF, Brizard CP. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training. Ann Thorac Surg. 2010;89:585-593, 593.e1-593.e4. doi: 10.1016/j.athoracsur.2009.10.035.
13. Hoashi T, Matsumiya G, Miyagawa S, Ichikawa H, Ueno T, Ono M, Saito A, Shimizu T, Okano T, Kawaguchi N, Matsuura N, Sawa Y. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J Thorac Cardiovasc Surg. 2009;138:460-467. doi: 10.1016/j.jtcvs.2009.02.018.
14. Tarui S, Sano S, Oh H. Stem cell therapies in patients with single ventricle physiology. Methodist Debakey Cardiovasc J. 2014;10:77-81.
15. Rupp S, Zeiher AM, Dimmeler S, Tonn T, Bauer J, Jux C, Akintuerk H, Schranz D. A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone mar-row- derived progenitor cells. J Heart Lung Transplant. 2010;29:574-577. doi: 10.1016/j.healun.2009.10.006.
16. Burkhart HM, Qureshi MY, Peral SC, O'Leary PW, Olson TM, Cetta F, Nelson TJ; The Wanek Program Clinical Pipeline G. Regenerative therapy for hypoplastic left heart syndrome: first report of intraoperative intramyocardial injection of autologous umbilical-cord blood-derived cells [published online ahead of print October 24, 2014]. J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2014.10.093. pii: S0022-5223(14)01602-X.
17. Morris CD, Outcalt J, Menashe VD. Hypoplastic left heart syndrome: natural history in a geographically defined population. Pediatrics. 1990;85:977-983.
18. Ohye RG, Sleeper LA, Mahony L, et al; Pediatric Heart Network I. Comparison of shunt types in the norwood procedure for single-ventricle lesions. New Engl J Med. 2010;362:1980-1992. doi: 10.1056/NEJMoa0912461.
19. Altmann K, Printz BF, Solowiejczky DE, Gersony WM, Quaegebeur J, Apfel HD. Two-dimensional echocardiographic assessment of right ventricular function as a predictor of outcome in hypoplastic left heart syndrome. Am J Cardiol. 2000;86:964-968.
20. Simpson DL, Mishra R, Sharma S, Goh SK, Deshmukh S, Kaushal S. A strong regenerative ability of cardiac stem cells derived from neonatal hearts. Circulation. 2012;126:S46-S53. doi: 10.1161/CIRCULATIONAHA.111.084699.
21. Malliaras K, Li TS, Luthringer D, et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched car-diosphere-derived cells. Circulation. 2012;125:100-112. doi: 10.1161/CIRCULATIONAHA.111.042598.
22. Suzuki G, Weil BR, Leiker MM, Ribbeck AE, Young RF, Cimato TR, Canty JM, Jr. Global intracoronary infusion of allogeneic cardiospherederived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium. PloS one. 2014;9:e113009.
23. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010;107:913-922. doi: 10.1161/CIRCRESAHA.110.22270.
24. Ghanayem NS, Allen KR, Tabbutt S, et al; Pediatric Heart Network I. Interstage mortality after the norwood procedure: results of the multicenter single ventricle reconstruction trial. J Thorac Cardiovasc Surg.2012;144:896-906. doi: 10.1016/j.jtcvs.2012.05.020.